4//SEC Filing
Mallon Mark 4
Accession 0001209191-20-028900
CIK 0001446847other
Filed
May 12, 8:00 PM ET
Accepted
May 13, 5:21 PM ET
Size
4.9 KB
Accession
0001209191-20-028900
Insider Transaction Report
Form 4
Mallon Mark
DirectorChief Executive Officer
Transactions
- Sale
Class A Common Stock
2020-05-11$10.35/sh−23,206$240,182→ 501,280 total
Footnotes (1)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on April 1, 2019.
Documents
Issuer
IRONWOOD PHARMACEUTICALS INC
CIK 0001446847
Entity typeother
Related Parties
1- filerCIK 0001763533
Filing Metadata
- Form type
- 4
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 5:21 PM ET
- Size
- 4.9 KB